Subscribe to RSS
DOI: 10.1055/a-2535-1067
Importance of oxyphil cells for 99mTc-sestamibi uptake in primary hyperparathyroidism: a retrospective observational study
Die Bedeutung oxyphiler Zellen für die 99mTc-Sestamibi Anreicherung bei primärem Hyperparathyreoidismus: eine retrospektive Beobachtungsstudie
Abstract
Aims
In patients with primary hyperparathyroidism (pHPT), the importance of oxyphil cells for 99mTc-sestamibi uptake is uncertain.
Methods
This retrospective observational study of pHPT patients evaluated independent associations between oxyphil cell content (OCC) and preoperative scintigraphic (SC) findings, using logistic regression analyses.
Results
We studied 76 patients with pHPT before and after operation. Preoperative SC was able to definitively identify abnormal parathyroid tissue in 47 patients (61.8%). The median relative OCC (postoperative histopathological examination) was 10% (IQR 0.25% – 40%) and the median absolute OCC was 0.09 cm3 (IQR 0.00 – 0.59 cm3). After adjustment for confounders, an iPTH concentration >200 pg/ml and increasing OCC was the only significant independent predictor of a definitively positive SC result (per category of relative OCC: adjusted odds ratio (aOR) 2.40, 95% confidence interval (CI) 1.02 – 5.65, p=0.045).
Conclusion
In patients with pHPT, a higher OCC was associated with a significantly higher probability of a clearly positive SC finding.
Keywords
primary hyperparathyroidism - parathyroid scintigraphy - oxyphil cell - parathyroid hormone - Tc99m-sestamibi uptakePublication History
Received: 02 October 2024
Accepted after revision: 06 February 2025
Article published online:
06 March 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 McBiles M, Lambert AT, Cote MG. et al. Sestamibi parathyroid imaging. Semin Nucl Med 1995; 25: 221-234
- 2 Shakeel S, Mubarak M. Proliferative Lesions of Parathyroid Glands: An Update for Practicing Pathologists. J Coll Physicians Surg Pak 2016; 26: 51-59
- 3 Coakley AJ, Kettle AG, Wells CP. et al. 99Tcm sestamibi – a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 791-794
- 4 Arbab AS, Koizumi K, Hemmi A. et al. 99mTc-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia. Ann Nucl Med 1997; 11: 45-49
- 5 Benard F, Lefebvre B, Beuvon F. et al. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 1995; 36: 241-243
- 6 Bleier BS, LiVolsi VA, Chalian AA. et al. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas. Arch Otolaryngol Head Neck Surg 2006; 132: 779-782
- 7 Carpentier A, Jeannotte S, Verreault J. et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998; 39: 1441-1444
- 8 Cordes M, Dworak O, Papadopoulos T. et al. MIBI scintigraphy of parathyroid adenomas: correlation with biochemical and histological markers. Endocr Res 2018; 43: 141-148
- 9 Durmus ET, Atmaca A, Kefeli M. et al. Clinicopathological variables that correlate with sestamibi positivity in uniglandular parathyroid disease: a retrospective analysis of 378 parathyroid adenomas. Ann Nucl Med 2022; 36: 33-42
- 10 Erbil Y, Kapran Y, Issever H. et al. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg 2008; 195: 34-39
- 11 Mehta NY, Ruda JM, Kapadia S. et al. Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue. Arch Otolaryngol Head Neck Surg 2005; 131: 493-498
- 12 Melloul M, Paz A, Koren R. et al. 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 2001; 28: 209-213
- 13 Mihai R, Gleeson F, Buley ID. et al. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 2006; 30: 697-704
- 14 Sandrock D, Merino MJ, Norton JA. et al. Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med 1993; 34: 24-29
- 15 Stephen AE, Roth SI, Fardo DW. et al. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg 2007; 142: 381-386
- 16 Westreich RW, Brandwein M, Mechanick JI. et al. Preoperative parathyroid localization: correlating false-negative technetium 99m sestamibi scans with parathyroid disease. Laryngoscope 2003; 113: 567-572
- 17 Bhatnagar A, Vezza PR, Bryan JA. et al. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med 1998; 39: 1617-1620
- 18 Cermik TF, Puyan FO, Sezer A. et al. Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism. Ann Nucl Med 2005; 19: 387-392
- 19 De la Hoz Rodriguez A, Munoz De Nova JL, Munoz Hernandez P. et al. Oxyphil cells in primary hyperparathyroidism: a clinicopathological study. Hormones (Athens) 2021; 20: 715-721
- 20 Howson P, Kruijff S, Aniss A. et al. Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation. Endocr Pathol 2015; 26: 250-254
- 21 Ishibashi M, Nishida H, Strauss HW. et al. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging. J Nucl Med 1997; 38: 706-711
- 22 Kobylecka M, Koperski L, Chudzinski W. et al. Relationship between parathyroid gland scintigraphy and its histopathology, oxyphil cell content and volume: a retrospective study. Nucl Med Rev Cent East Eur 2019; 22: 29-33
- 23 Pinero A, Rodriguez JM, Ortiz S. et al. Relation of biochemical, cytologic, and morphologic parameters to the result of gammagraphy with technetium 99m sestamibi in primary hyperparathyroidism. Otolaryngol Head Neck Surg 2000; 122: 851-855
- 24 Staudenherz A, Abela C, Niederle B. et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997; 24: 143-149
- 25 Takebayashi S, Hidai H, Chiba T. et al. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 1999; 40: 1792-1797
- 26 Turgut B, Elagoz S, Erselcan T. et al. Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging: relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volume. Cancer Biother Radiopharm 2006; 21: 579-590
- 27 Ugur O, Bozkurt MF, Hamaloglu E. et al. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 2004; 139: 1175-1179
- 28 Thompson GB, Mullan BP, Grant CS. et al. Parathyroid imaging with technetium-99m-sestamibi: an initial institutional experience. Surgery 1994; 116: 966-972 ; discussion 972–963
- 29 Neuberger M, Dropmann JA, Kleespies A. et al. Determinants and clinical significance of negative scintigraphic findings in primary hyperparathyroidism: a retrospective observational study. Nuklearmedizin 2022; 61: 440-448
- 30 Peduzzi P, Concato J, Kemper E. et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373-1379
- 31 Ruda JM, Hollenbeak CS, Stack BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132: 359-372
- 32 Wilhelm SM, Wang TS, Ruan DT. et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 2016; 151: 959-968
- 33 Caveny SA, Klingensmith 3rd WC, Martin WE. et al. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I. J Nucl Med Technol 2012; 40: 104-110
- 34 Van De Flierdt E, Dropmann A, Bock J. et al. Primärer Hyperparathyreoidismus: Nebenschilddrüsenszintigraphie und Sonographie bei Problempatienten. Chirurg 2004; 75: 794-798
- 35 Hosmer DW, David W, Hosmer SL. et al. Applied Survival Analysis: Time-to-Event. New York: Wiley; 1999
- 36 Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 1989